中文 | English
Return
Total: 632 , 1/64
Show Home Prev Next End page: GO
Author:(Wei-min FANG)

1.Differences in deltamethrin resistance and kdr gene mutation in Culex tritaeniorhynchus population in and outside the Yellow Sea wetland

Xiao-er ZHANG ; Zhi-ming WU ; Ye TIAN ; Qian CUI ; Yu-qian JI ; Huan WANG ; Shu-juan YANG ; Yi-chao ZHAO ; Yu WANG ; Hua-yu YIN ; Yu DING ; Guo-jin YAN ; Min-sen ZHAO ; Shou-gang ZHANG ; Bing-dong SONG ; Hong-na CHEN ; Jian GAO ; Wei-fang YANG ; Yu-fu ZHANG ; Hui LIU ; Hong-liang CHU

Acta Parasitologica et Medica Entomologica Sinica 2026;33(2):101-107

2.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

3.Atomic force microscopic observation of surface structure of purified protein molecules in vitro

Zhao-ying CHEN ; Xiao-feng FANG ; Dan-yan LIU ; Meng-qin CHEN ; Xi LING ; Jie-min ZHAO ; Wei WEI ; Yu-jing WU

Chinese Pharmacological Bulletin 2025;41(1):193-199

4.Expert Consensus on the Ethical Requirements for Generative AI-Assisted Academic Writing

You-Quan BU ; Yong-Fu CAO ; Zeng-Yi CHANG ; Hong-Yu CHEN ; Xiao-Wei CHEN ; Yuan-Yuan CHEN ; Zhu-Cheng CHEN ; Rui DENG ; Jie DING ; Zhong-Kai FAN ; Guo-Quan GAO ; Xu GAO ; Lan HU ; Xiao-Qing HU ; Hong-Ti JIA ; Ying KONG ; En-Min LI ; Ling LI ; Yu-Hua LI ; Jun-Rong LIU ; Zhi-Qiang LIU ; Ya-Ping LUO ; Xue-Mei LV ; Yan-Xi PEI ; Xiao-Zhong PENG ; Qi-Qun TANG ; You WAN ; Yong WANG ; Ming-Xu WANG ; Xian WANG ; Guang-Kuan XIE ; Jun XIE ; Xiao-Hua YAN ; Mei YIN ; Zhong-Shan YU ; Chun-Yan ZHOU ; Rui-Fang ZHU

Chinese Journal of Biochemistry and Molecular Biology 2025;41(6):826-832

5.Mechanism of NR4A1 regulating IFN-γ in UUO-induced renal fibrosis

Hongshuang WANG ; Fang FANG ; Jieqi NIU ; Zheng WANG ; Yan ZHONG ; Min WEI ; Xiangting WANG

Chinese Journal of Pathophysiology 2025;41(11):2221-2228

6.Establishment of preparation process and quality standard for Zhenggu Pills

Wen-ming ZHANG ; Zi-fang FENG ; Li-hong GU ; Ping QIN ; Zhen-hua BIAN ; Min-min HU ; Xiao-wei CHEN

Chinese Traditional Patent Medicine 2025;47(9):2863-2869

7.Andrographolide as a Multi-Target Therapeutic Agent in Diabetic Nephropathy: Insights into STAT3/PI3K/Akt Pathway Modulation

Yuan YIN ; Jing HE ; Yu FANG ; Min WEI ; Wang ZHANG

Biomolecules & Therapeutics 2025;33(3):529-543

8.Andrographolide as a Multi-Target Therapeutic Agent in Diabetic Nephropathy: Insights into STAT3/PI3K/Akt Pathway Modulation

Yuan YIN ; Jing HE ; Yu FANG ; Min WEI ; Wang ZHANG

Biomolecules & Therapeutics 2025;33(3):529-543

9.Andrographolide as a Multi-Target Therapeutic Agent in Diabetic Nephropathy: Insights into STAT3/PI3K/Akt Pathway Modulation

Yuan YIN ; Jing HE ; Yu FANG ; Min WEI ; Wang ZHANG

Biomolecules & Therapeutics 2025;33(3):529-543

10.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 632 , 1/64 Show Home Prev Next End page: GO